To hear about similar clinical trials, please enter your email below
Trial Title:
Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker
NCT ID:
NCT05501379
Condition:
Lymphoma
Pancreas Cancer
Colorectal Cancer
Conditions: Official terms:
Pancreatic Neoplasms
Conditions: Keywords:
Physical Activity
Accelerometer
International Physical Activity Questionnaire
Cancer Therapy
GeneActiv
Quality of Life
Fatigue
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
No intervention - observational study only
Description:
No intervention - observational study only
Arm group label:
Cancer Patients
Summary:
Physical activity is an important aspect of cancer therapy but correct measurement of
physical activity is difficult. In this study, the physical activity of patients
undergoing cancer therapy is assessed by questionnaire and by motion tracker. The results
are then compared to answer whether there are differences between the two measurements.
Findings of this study will help to improve the assessment of physical activity in cancer
patients.
Detailed description:
Although physical activity has been identified as a relevant determinant of cancer
therapy outcome, its valid assessment remains challenging. In principle, direct and
indirect assessment instruments can be employed for assessment of physical activity.
While direct instruments, e.g. accelerometers, are considered to provide a more objective
measurement, indirect tools such as questionnaires are less expensive and more applicable
for use in larger study populations. The validity of both forms of measurements in cancer
patients is however not well studied. Therefore, this study aims to elucidate the
relative validity of an accelerometer in comparison to a standardized physical
questionnaire at different time points of cancer therapy. Findings of this study will
allow conclusions regarding the ideal modalities for assessment of physical activity in
cancer patients.
Criteria for eligibility:
Study pop:
Patients will be recruited at University Medicine Greifswald (Northeast Germany).
Patients with the verified diagnosis of lymphoma, colerectal or pancreatic cancer
requiring surgical, chemo or radio therapy will be identified in the respective wards or
day care units of the hosptial.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- verified diagnosis of lymphoma, colorectal or pancreatic cancer
- requirement of surgical, chemo or radio therapy
- provision of informed consent
Exclusion Criteria:
- pregnancy
- inability to provide consent
- use of a rollator
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
University Medicine Greifswald
Address:
City:
Greifswald
Zip:
17475
Country:
Germany
Status:
Recruiting
Contact:
Last name:
Ali A Aghdassi, Professor
Phone:
+493834867230
Email:
ali.aghdassi@med.uni-greifswald.de
Investigator:
Last name:
Ali A Aghdassi, Professor
Email:
Principal Investigator
Investigator:
Last name:
Mats L Wiese, MSc
Email:
Sub-Investigator
Investigator:
Last name:
Sebastian Schmidt
Email:
Sub-Investigator
Start date:
September 21, 2022
Completion date:
October 2024
Lead sponsor:
Agency:
University Medicine Greifswald
Agency class:
Other
Source:
University Medicine Greifswald
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05501379
